Testing effectiveness (Phase 2)Study completedNCT02888080
What this trial is testing
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis
Who this might be right for
Pulmonary Sarcoidosis
Novartis Pharmaceuticals 40